Aug 9, 2017   SOURCE: PR NewsWire

Extracorporeal Membrane Oxygenation Machine Market to Reach $305 Million by 2021: Analysis By Modality, Application & Region

DUBLIN, August 9, 2017 /PRNewswire/ --

The "Extracorporeal Membrane Oxygenation Machine Market by Modality, Application and Region - Analysis & Forecasts to 2021" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global extracorporeal membrane oxygenation (ECMO) machine market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.

The global market is segmented on the basis of modality, application, and region. By modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is accounted for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, increasing incidence of COPD, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.

Based on application, the market is segmented into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment is estimated to grow at the highest CAGR in the forecast period, due to factors such as the rising incidence of respiratory failure, lung cancer, and lung transplants, growing ECMO centers, and the increasing adoption of ECMO in hospitals.

On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America accounted for the largest share of the global market, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is expected to grow at the highest CAGR and serve as a revenue pocket for companies offering ECMO systems. Moreover, the growth is attributed to factors such as growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences & training programs to increase awareness, and technological advancements.

A majority of the leading players in the market is focusing on approvals, product launches, agreements, partnerships, expansions, and acquisitions to expand their product portfolios and customer bases, enhance their sales channels, and increase their global presence.

Companies Mentioned 

    --  Alung Technologies, Inc.
    --  Eurosets S.R.L.
    --  Getinge Group
    --  Livanova PLC
    --  Medtronic PLC
    --  Microport Scientific Corporation
    --  Nipro Corporation
    --  Origen Biomedical, Inc.
    --  Terumo Corporation
    --  Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Global Extracorporeal Membrane Oxygenation Machine Market, By Modality

7 Global Extracorporeal Membrane Oxygenation Machine Market, By Application

8 Extracorporeal Membrane Oxygenation Machine Market, By Region

9 Competitive Landscape

10 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/c27bp6/extracorporeal

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/extracorporeal-membrane-oxygenation-machine-market-to-reach-305-million-by-2021-analysis-by-modality-application--region-300501938.html

SOURCE Research and Markets